Get started
Author

Alexander W. den Hartog

Observed names: A Den Hartog, A W Den Hartog, A W den Hartog, A. Den Hartog, A. W. Den Hartog, A. W. Hartog, A. W. den Hartog, Alexander W. den Hartog, Alexander W Hartog, Alexander W den Hartog, Alexander W. Den Hartog, Alexander Willem den Hartog, Alexander Willem hartog, Alexander den Hartog, Hartog, A.W. den
Observed institutions: University Medical Center Groningen, Radboud University Nijmegen, Leiden University Medical Center, Amsterdam UMC Location University of Amsterdam, Radboud University Medical Center, Netherlands Heart Institute, Amsterdam University Medical Centers, Amsterdam Cardiovascular Sciences, Vrije Universiteit Amsterdam, University of Amsterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam
ORCID: 0000-0003-1700-9514
Observed ORCIDs: 0000-0003-1700-9514, 0009-0007-1800-5829
OpenAlex ID: A5020398938
Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial
2013 · M. Groenink, A. W. den Hartog, et al. · European Heart Journal · 402
Beneficial Outcome of Losartan Therapy Depends on Type of FBN1 Mutation in Marfan Syndrome
2015 · Romy Franken, Alexander W. den Hartog, et al. · Circulation Cardiovascular Genetics · 176
PDF
The Risk for Type B Aortic Dissection in Marfan Syndrome
2015 · Alexander W. den Hartog, Romy Franken, et al. · Journal of the American College of Cardiology · 154
Circulating transforming growth factor-β as a prognostic biomarker in Marfan syndrome
2013 · Romy Franken, Alexander W. den Hartog, et al. · International Journal of Cardiology · 80
The influence of rewarming after therapeutic hypothermia on outcome after cardiac arrest
2012 · Aline Bouwes, Laure B.M. Robillard, et al. · Resuscitation · 77
Spontaneous hypothermia on intensive care unit admission is a predictor of unfavorable neurological outcome in patients after resuscitation: an observational cohort study
2010 · Alexander W den Hartog, Anne-Cornélie JM de Pont, et al. · Critical Care · 53
PDF
The revised role of TGF-β in aortic aneurysms in Marfan syndrome
2014 · COMPARE study group, R. Franken, et al. · Netherlands Heart Journal · 46
PDF
Single antiplatelet therapy directly after percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients: the OPTICA study
2023 · Niels M.R. van der Sangen, Bimmer E.P.M. Claessen, et al. · EuroIntervention · 35
PDF
Current and future pharmacological treatment strategies with regard to aortic disease in Marfan syndrome
2012 · Alexander W Hartog, Romy Franken, et al. · Expert Opinion on Pharmacotherapy · 29
Aortic Disease in Patients with Marfan Syndrome: Aortic Volume Assessment for Surveillance
2013 · Alexander W. den Hartog, Romy Franken, et al. · Radiology · 28
Sirolimus-Eluting Balloon With Provisional Stenting Versus Systematic Drug-Eluting Stent Implantation to Treat De Novo Coronary Lesions: A Randomized, Open-Label, Noninferiority Trial
2026 · Christian Spaulding, Florian Krackhardt, et al. · Circulation · 26
Paclitaxel-coated balloons for vulnerable lipid-rich plaques
2024 · Anna van Veelen, I. Tarik Küçük, et al. · EuroIntervention · 25
PDF
Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology
2023 · Ramesh Nadarajah, Peter Ludman, et al. · European Heart Journal - Quality of Care and Clinical Outcomes · 24
PDF
No Beneficial Effect of General and Specific Anti-Inflammatory Therapies on Aortic Dilatation in Marfan Mice
2014 · Romy Franken, Stijntje Hibender, et al. · PLoS ONE · 24
PDF
Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry
2022 · Ramesh Nadarajah, Peter Ludman, et al. · European Heart Journal - Quality of Care and Clinical Outcomes · 20
PDF
Clinical Features Differ Substantially Between Caucasian and Asian Populations of Marfan Syndrome
2013 · Romy Franken, Alexander W. den Hartog, et al. · Circulation Journal · 20
PDF
The effect of losartan therapy on ventricular function in Marfan patients with haploinsufficient or dominant negative FBN1 mutations
2016 · A. W. den Hartog, R. Franken, et al. · Netherlands Heart Journal · 18
PDF
Recurrent syncope due to glossopharyngeal neuralgia
2016 · Alexander W. den Hartog, Evelien Jansen, et al. · HeartRhythm Case Reports · 16
Marfan syndrome: Progress report
2012 · Romy Franken, Alexander W. den Hartog, et al. · Progress in Pediatric Cardiology · 16
First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study
2023 · Anna van Veelen, I. Tarik Küçük, et al. · Journal of Clinical Medicine · 12
PDF
Early-stage health technology assessment of fractional flow reserve coronary computed tomography versus standard diagnostics in patients with stable chest pain in The Netherlands
2024 · Iris W. A. Boot, R. Nils Planken, et al. · PLoS ONE · 6
One-year follow-up of patients treated with single antiplatelet therapy directly after percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome
2023 · Niels M R van der Sangen, Bimmer E P M Claessen, et al. · European Heart Journal Open · 4
PDF
P2Y12-inhibitor monotherapy after coronary stenting: are all P2Y12-inhibitors equal?
2022 · Niels MR van der Sangen, I Tarik Küçük, et al. · Expert Review of Cardiovascular Therapy · 3
Coronary angiography in cardiac arrest patients undergoing extracorporeal cardiopulmonary resuscitation
2026 · Margriet Bogerd, Jarno N. R. de Haas, et al. · Netherlands Heart Journal · 2
PDF
The Impact of Hydrostatic Pressure on Fractional Flow Reserve in Saphenous Vein Grafts
2025 · Roel Hoek, Sina Porouchani, et al. · Catheterization and Cardiovascular Interventions · 2
PDF
Works count: 56
Citation count: 1,306
H-index: 17
I10-index: 20
Year
Topic
Type